Related Experiment Video
Updated: Nov 4, 2025

Injection of dsRNA into Female A. aegypti Mosquitos
Published on: July 4, 2007
Aedes aegypti Toll pathway is induced through dsRNA sensing in endosomes
Yesseinia I Angleró-Rodríguez1, Chinmay V Tikhe1, Seokyoung Kang1
1Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, United States.
Abstract:
Mosquito anti-pathogen immune responses, including those controlling infection with arboviruses are regulated by multiple signal transduction pathways. While the Toll pathway is critical in the defense against arboviruses such as dengue and Zika viruses, the factors and mechanisms involved in virus recognition leading to the activation of the Toll pathway are not fully understood. In this study we evaluated the role of virus-produced double-stranded RNA (dsRNA) intermediates in mosquito immune activation by utilizing the synthetic dsRNA analog polyinosinic-polycytidylic acid (poly I:C). Poly I:C treatment of Aedes aegypti mosquitoes and Aag2 cells reduced DENV infection. Transcriptomic analyses of Aag2 cell responses to poly I:C indicated putative activation of the Toll pathway. We found that poly I:C is translocated to the endosomal compartment of Aag2 cells, and that the A. aegypti Toll 6 receptor is a putative dsRNA recognition receptor. This study elucidates the role of dsRNAs in the immune activation of non-RNAi pathways in mosquitoes.
Insights
Mosquitoes use double-stranded RNA (dsRNA) to activate immune defenses against viruses like dengue. Researchers identified a specific receptor involved in this mosquito immune response, enhancing our understanding of arbovirus control.
Area of Science:
- * Mosquito immunology
- * Molecular biology
- * Arbovirus research
Background:
- * Mosquitoes possess complex immune responses to combat pathogens, including arboviruses.
- * The Toll pathway is crucial for defending against viruses like dengue and Zika, but virus recognition mechanisms remain unclear.
- * Double-stranded RNA (dsRNA) is a key viral intermediate, but its role in activating non-RNAi mosquito immunity is not fully understood.
Purpose of the Study:
- * To investigate the role of viral double-stranded RNA (dsRNA) in activating mosquito immune responses.
- * To identify the mechanisms and receptors involved in dsRNA recognition and subsequent immune pathway activation.
- * To explore the potential of dsRNA analogs for controlling arbovirus infections in mosquitoes.
Main Methods:
- * Treatment of *Aedes aegypti* mosquitoes and Aag2 cells with polyinosinic-polycytidylic acid (poly I:C), a synthetic dsRNA analog.
- * Assessment of DENV infection levels post-treatment.
- * Transcriptomic analysis of Aag2 cells in response to poly I:C.
- * Cellular localization studies of poly I:C and identification of potential dsRNA receptors.
Main Results:
- * Poly I:C treatment significantly reduced DENV infection in *Aedes aegypti* mosquitoes and Aag2 cells.
- * Transcriptomic data suggested activation of the Toll pathway following poly I:C exposure.
- * Poly I:C was observed to translocate to the endosomal compartment in Aag2 cells.
- * The *A. aegypti* Toll 6 receptor was identified as a putative receptor for dsRNA recognition.
Conclusions:
- * Virus-produced dsRNAs are potent activators of mosquito anti-pathogen immune responses.
- * The *A. aegypti* Toll 6 receptor plays a role in recognizing dsRNA and initiating immune signaling.
- * This study elucidates dsRNA's function in activating non-RNAi immune pathways in mosquitoes, offering insights into arbovirus control strategies.
Related Concept Videos
Receptor-mediated Endocytosis
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
MAPK Signaling Cascades
Experimental RNAi
Intracellular Signaling Cascades
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

